Detection of PD-L1 protein expression level by immunohistochemistry
-
Innovative product developed by Shuwen Biotech
-
High concordance of testing results with FDA-approved PD-L1 reagent
-
Routinely used for non-small cell lung cancer, gastric cancer, triple-negative breast cancer, bladder cancer, nasopharyngeal cancer and other cancers
-
It can provide TC/TPS, CPS, IC and other multi-index interpretation
-
Reasonable price, each test takes as little as 100 μL
-
Suitable for Leica, Baidao, Wanfu and other imported/domestic automation equipment
Registration record number